Building Terray Therapeutics – Bridging the Gap Between Drug Discovery and Treatment
37:45 Share

Madrona Partner, Chris Picardo, sits down with Terray Therapeutics founders (and brothers), Jacob and Eli Berlin as well as data scientist, Narbe Mardirossian to talk about the power of bringing together transformational wet lab processes with ML and AI to speed drug development.  Terray Therapeutics announced their Series A of $60 million in February of 2022 and this podcast follows that announcement.